Meyersohn, N. M., Mayrhofer, T., Ivanov, A., Bittner, D. O., Staziaki, P. V., Szilveszter, B., … Ferencik, M. (2018). Association of hepatic steatosis with adverse cardiovascular events: insights from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial. In EUROPEAN HEART JOURNAL (Vol. 39, pp. 1286–1286). Munich, GERMANY: OXFORD UNIV PRESS.

Meyersohn, N. M., T. Mayrhofer, A. Ivanov, D. O. Bittner, P. V. Staziaki, B. Szilveszter, T. Hallett, et al. “Association of hepatic steatosis with adverse cardiovascular events: insights from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial.” In EUROPEAN HEART JOURNAL, 39:1286–1286. OXFORD UNIV PRESS, 2018.

Meyersohn NM, Mayrhofer T, Ivanov A, Bittner DO, Staziaki PV, Szilveszter B, et al. Association of hepatic steatosis with adverse cardiovascular events: insights from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2018. p. 1286–1286.

Meyersohn, N. M., et al. “Association of hepatic steatosis with adverse cardiovascular events: insights from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial.” EUROPEAN HEART JOURNAL, vol. 39, OXFORD UNIV PRESS, 2018, pp. 1286–1286.

Meyersohn NM, Mayrhofer T, Ivanov A, Bittner DO, Staziaki PV, Szilveszter B, Hallett T, Lu ML, Puchner SB, Simon TG, Corey KE, Ginsburg GS, Douglas PS, Hoffmann U, Ferencik M. Association of hepatic steatosis with adverse cardiovascular events: insights from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2018. p. 1286–1286.